米国証券取引委員会への Form 8-K の提出ジェー・ピー・モルガン

1
平成 26 年 12 月 8 日
会社名
ジェー・ピー・モルガン・チェース
(JPMorgan Chase & Co)
代表者名
ジェームズ・ダイモン
(James Dimon)
最高経営責任者 (CEO)兼社長
86340 東証第一部外国株）
（コード番号
問合せ先
東京
アン
弁護
弁護
TEL
都港区元赤坂一
ダーソン・毛利
士
中村
慎二
士
辻本
晴子
03-6888-1000
& カンパニー
丁目２番７号赤坂Ｋタワー
・友常法律事務所
/弁護士
早瀨
孝広
/弁護士
椙弘
真人
米国証券取引委員会への Form 8-K の提出
ジェー・ピー・モルガン・チェース & カンパニーは、 2014 年 12 月 5 日付
で、米国証券取引委員会に Form 8-K を提出いたしました。内容については添
付をご参照ください。
L2-#694018
JPMORGAN CHASE & CO
FORM
8-K
(Current report filing)
Filed 12/05/14 for the Period Ending 12/05/14
Address
Telephone
CIK
Symbol
Fiscal Year
270 PARK AVE
38TH FL
NEW YORK, NY 10017
2122706000
0000019617
JPM
12/31
http://www.edgar-online.com
© Copyright 2014, EDGAR Online, Inc. All Rights Reserved.
Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 5, 2014
JPMorgan Chase & Co.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1-5805
(Commission File Number)
13-2624428
(I.R.S. employer
identification no.)
270 Park Avenue, New York, New
York
(Address of principal executive offices)
10017
(Zip Code)
Registrant’s telephone number, including area code: (212) 270-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On December 5, 2014, Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co., distributed a note to colleagues
updating them on his health. A copy of his note is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No.
99.1
Description of Exhibit
Note of Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
JPMorgan Chase & Co.
(Registrant)
By:
Dated:
December 5, 2014
3
/s/ Anthony J. Horan
Anthony J. Horan
Corporate Secretary
INDEX TO EXHIBITS
Exhibit No.
99.1
Description of Exhibit
Note of Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co.
4
Exhibit 99.1
Dear ColleaguesThis past summer, I let you know that I had been diagnosed with throat cancer. Having concluded my full treatment regimen a few months ago,
I wanted to give you an update on my health. This week I had the thorough round of tests and scans that are normally done three months
following treatment, including a CAT scan and a PET scan. The good news is that the results came back completely clear, showing no evidence
of cancer in my body. While the monitoring will continue for several years, the results are extremely positive and my prognosis remains
excellent.
As always, and especially since my diagnosis, I followed the advice I give to others-take care of your health first-nothing is more important.
Throughout this journey, I was blessed with the love and support of my family, friends and colleagues, and I received an outpouring of heartfelt
warm wishes and messages from thousands of others, which meant so much to me.
I’m very proud to be part of this company and it’s an inspiration to work with such an exceptional group of people.
With deep gratitude and respect,
Jamie

Download Report